I wrote this two years ago, from a Medscape site. After all this time and the advances in knowledge since the I'm repeating it here, Note the difference in half-life of NDT T3, consderably longer than synthetic T3 (2.5 days versus 1 day). This is the ammunition which shows that NDT T3 is mostly protein bound and this causes delay in uptake until the protein thyroglobulin has been almost entirely degraded to release the T3 for uptake in cells. This is a secret weapon that Bianco would wish to bury, because his artifiical compound of T3 works little better.
Pharmacokinetics of NDT (DTE)diogenes•2 years ago•9 RepliesI discovered some useful information on NDT pharmacokinetics (rate of uptake, time to achieve peak level in blood, and loss rate). Note that >99% is protein bound, mainly onto thyroglobulin, so it will take time for the hormones to be released from the protein in the stomach/intestine and explains the delay in initial effect and the time it takes to achieve peak level, especially T3. Also we know that T3 taken on its own has a halflife of 1 day, yet it takes 2-.5 days to reach peak level. again indicating slower pharmacokinetics than T3 alone. T4-NDT half-life doesn't seem to differ from T4 alone. The different bioavailability also suggests slower uptake of NDT.Mechanism of ActionNatural thyroid hormone from animals; increase basal metabolic rate, increase utilization and mobilization of glycogen store, promotes gluconeogenesisPharmacokinetics
Onset: Initial effect: 3hr
Bioavailability: 48-80%Protein Bound: >99%
Metabolism: Hepatic; also in kidney and intestinal walls
Metabolites in NDT: Levothyroxine (T4), liothyronine (T3)
Excretion: Urine (major), feces (partially)
Time to peakT4: 2-4 hr
T3: 2-3 days
Half-LifeT4: 6-7 days (euthyroid); T3: 2.5 days